IBER.U

Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U

Overview Fund Activity
Delisted

IBER.U was delisted on the 1st of March, 2023.

Back to rankings

23 hedge funds and large institutions have $40.2M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 7 closing their positions.

Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
1
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
KC
1
Kryger Capital
United Kingdom
$3.86M
2
SIA
2
Schechter Investment Advisors
Michigan
$2.11M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$516K
4
UBS Group
4
UBS Group
Switzerland
$3K

Top Sellers

1
SCM
1
Shaolin Capital Management
Florida
$0
2
PC
2
Periscope Capital
Ontario, Canada
$0
3
GCL
3
Glazer Capital LLC
New York
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
Walleye Capital
5
Walleye Capital
New York
$109K
Name Market Value Shares Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
– – -134,735 Closed
Walleye Trading
27
Walleye Trading
New York
– – -80,000 Closed
HP
28
Hound Partners
New York
– – -49,867 Closed
EH
29
EMG Holdings
Connecticut
– – -10,000 Closed
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
CS
31
Clear Street
New York
$0 41 +41 New
1
2